impact
vaccin
public
health
wellb
profound
smallpox
erad
polio
near
erad
multipl
diseas
elimin
certain
area
world
unfortun
face
diseas
hepat
c
malaria
tuberculosi
well
new
reemerg
pathogen
lack
effect
vaccin
empir
approach
vaccin
develop
success
past
may
current
infecti
diseas
challeng
face
us
new
direct
approach
vaccin
design
develop
test
need
develop
ideal
approach
capit
cuttingedg
technolog
advanc
analyt
model
strategi
uptod
knowledg
pathogen
host
approach
pay
particular
attent
caus
interindividu
variat
vaccin
respons
order
develop
new
vaccin
tailor
uniqu
need
individu
commun
within
popul
vaccin
repres
one
medicin
greatest
achiev
vaccin
systemat
reduc
mortal
morbid
rate
infecti
diseas
save
countless
live
one
first
vaccin
develop
smallpox
vaccin
initi
base
cowpox
viru
edward
jenner
use
vaccin
worldwid
led
world
health
organ
erad
campaign
last
natur
occur
case
smallpox
seen
diseas
declar
erad
develop
licensur
use
inactiv
polioviru
vaccin
ipv
led
decreas
polio
case
follow
develop
use
oral
polioviru
vaccin
opv
reduct
incid
rate
diseas
togeth
vaccin
prevent
million
case
polio
associ
crippl
effect
phenomen
success
vaccin
led
adopt
goal
global
polio
erad
polio
rate
decreas
sinc
erad
effort
start
hundr
case
per
year
mostli
afghanistan
pakistan
nigeria
neighbor
countri
unfortun
previous
poliofre
countri
experienc
outbreak
due
import
case
make
continu
vaccin
program
essenti
final
erad
effort
concern
safeti
oral
polioviru
vaccin
shift
vaccin
usag
ipv
use
vaccin
entir
posit
rotashield
rotaviru
vaccin
develop
wyeth
licens
howev
littl
one
year
later
wyeth
remov
rotashield
market
advisori
committe
immun
practic
acip
withdrew
recommend
use
due
increas
risk
intussuscept
rare
lifethreaten
intestin
disord
children
vaccin
next
sever
year
addit
formul
would
licens
rotateq
merck
rotarix
glaxosmithklein
importantli
new
product
licens
largescal
trial
specif
evalu
risk
intussuscept
purpos
vaccin
provok
benefici
immun
respons
recipi
vast
major
time
respons
result
protect
immun
accompani
temporari
discomfort
howev
vaccin
product
much
like
medicin
medic
procedur
side
effect
although
typic
minor
temporari
side
effect
seriou
lifethreaten
real
way
vaccin
victim
success
initi
substanti
risk
diseas
far
outweigh
minim
risk
associ
vaccin
vaccin
rate
rise
diseas
incid
fall
therebi
chang
riskreward
balanc
mani
case
public
percept
risk
reward
balanc
chang
rather
actual
riskreward
balanc
polio
measl
mump
pertussi
mani
diseas
may
consid
rare
concern
histor
diseas
longer
affect
peopl
diseas
occur
distant
region
world
diseas
simpli
minor
worri
gener
public
perceiv
risk
diseas
minim
vaccinerel
side
effect
real
imagin
hype
media
realiti
diseas
seriou
public
health
threat
measl
mortal
rate
per
case
pertussi
mortal
rate
diphtheria
fatal
rate
overal
younger
children
mani
region
world
experienc
signific
increas
measl
outbreak
last
sever
year
case
measl
case
rubella
europ
alon
data
earli
indic
number
like
increas
outbreak
direct
result
decreas
vaccin
coverag
caus
larg
part
unwarr
fear
concern
measl
vaccin
autism
justifi
current
live
societi
heighten
concern
regard
vaccin
safeti
led
remov
thimeros
vaccin
formul
well
adjust
vaccin
schedul
also
rais
bar
clinic
trial
safeti
data
requir
licensur
predict
advers
event
side
effect
due
vaccin
becom
import
process
vaccin
develop
recent
vaccin
develop
follow
onesizefitsal
approach
character
empir
method
describ
isol
inactiveattenu
inject
paradigm
straightforward
approach
remark
success
past
unfortun
reach
point
diminish
return
especi
complex
pathogen
approach
also
ignor
increas
understand
innat
adapt
immun
respons
variat
host
genet
effect
age
gender
race
ethnic
microbiom
even
diet
nutrit
also
overlook
hostpathogen
interact
overemphas
humor
immun
respons
dealt
variat
pathogen
genet
creat
differ
product
differ
strain
polio
pneumococc
vaccin
yearli
reformul
influenza
vaccin
ultim
goal
vaccin
research
commun
develop
safer
effect
vaccin
enhanc
public
health
review
focu
current
technolog
scientif
advanc
vaccin
research
applic
predict
vaccineinduc
immun
respons
includ
role
innat
immun
respons
establish
adapt
immun
use
adjuv
enhanc
immun
effect
microbiom
immun
respons
influenc
host
genet
variat
vaccin
respons
role
system
biolog
approach
understand
predict
immun
vaccin
like
develop
effect
vaccin
counter
current
public
health
threat
requir
new
approach
vaccinolog
call
new
approach
vaccinom
approach
inform
detail
understand
critic
compon
effect
immun
respons
mechanist
system
level
figur
essenti
element
new
approach
recognit
vaccin
recipi
repres
wide
divers
popul
popul
respond
given
vaccin
wide
spectrum
immun
respons
men
women
exhibit
differ
immun
respons
vaccin
andor
infect
phenomenon
seen
multipl
virus
rhinovirus
cmv
dengu
ebv
hbv
hcv
influenza
measl
wnv
mediat
part
hormon
differ
idea
divers
popul
vari
respons
immun
might
requir
differ
vaccin
optim
protect
term
person
vaccinolog
much
like
person
medicin
impact
field
pharmacolog
cancer
begin
see
move
toward
person
vaccinolog
influenza
vaccin
excel
exampl
influenza
season
five
differ
type
vaccin
avail
gear
toward
specif
segment
popul
tabl
influenza
vaccin
contain
antigen
three
four
viral
strain
multipl
formul
standard
dose
inactiv
vaccin
age
rang
recommend
two
dose
infant
children
never
receiv
influenza
vaccin
high
dose
vaccin
intend
overcom
immunosenesc
older
elderli
individu
recombin
formul
produc
insect
cell
allergi
egg
egg
protein
product
contain
live
attenu
viru
thought
better
mimic
real
infect
low
dose
intraderm
vaccin
deliv
antigen
skinresid
apc
market
antigen
spare
needl
smaller
flu
shot
undoubtedli
market
forc
profit
motiv
contribut
increas
product
line
would
argu
new
product
meet
need
popul
group
eggbas
allergi
elderli
name
success
therefor
longterm
interest
vaccin
manufactur
develop
new
vaccin
success
address
limit
current
vaccin
given
increas
emphasi
person
medicin
like
trend
see
influenza
vaccin
expand
vaccin
well
critic
element
person
vaccinolog
well
new
direct
vaccin
develop
approach
abil
predict
vaccin
respons
summari
use
systemslevel
analys
better
understand
immun
respons
offer
promis
inform
approach
new
vaccin
develop
appreci
effect
genet
nongenet
influenc
immun
respons
develop
novel
biomark
vaccin
respons
creation
predict
model
allow
us
select
appropri
vaccin
product
identifi
avoid
advers
respons
therebi
creat
safer
yet
still
effect
vaccin
current
futur
public
health
threat
past
decad
seen
dramat
increas
studi
focus
innat
immun
innat
immun
repres
key
element
host
immun
respons
infect
vaccin
importantli
innat
respons
perform
three
key
function
immedi
recognit
pathogen
nonspecif
defens
mechan
halt
infecti
process
initi
power
antigenspecif
adapt
immun
respons
stimul
innat
immun
start
repertoir
innat
sensor
tolllik
receptor
tlr
rigilik
receptor
cytosol
dna
sensor
other
recogn
differ
pathogenassoci
molecular
pattern
pamp
includ
lipopolysaccharid
lp
lipoprotein
lipopeptid
lipoarabinomannan
bacteri
flagellin
viral
glycoprotein
doublestrand
rna
virus
unmethyl
cpg
site
bacteri
viral
dna
well
rna
dna
molecul
human
tlr
endosom
special
viral
recognit
antivir
host
respons
upon
viral
infect
engag
pathogen
recognit
receptor
trigger
intracellular
signal
cascad
lead
activ
wide
varieti
defens
mechan
includ
cytokin
andor
chemokin
secret
upregul
cytokin
receptor
induct
type
iii
interferon
product
antivir
effector
protein
activ
host
defens
pathway
eg
dsrnaactiv
protein
kinas
r
ribonucleas
l
pathway
mx
protein
adenosin
deaminas
rnaspecif
ubiquitinlik
pathway
etc
multipl
cytokin
chemokin
also
produc
respons
pathogen
recognit
collect
defens
mechan
limit
replic
spread
pathogen
within
host
third
import
function
innat
immun
aid
prime
develop
adapt
immun
specif
elimin
pathogen
andor
pathogeninfect
cell
mani
effector
mechan
also
affect
antigen
present
cell
result
upregul
costimulatori
molecul
enhanc
express
mhc
ii
molecul
increas
phagocytosi
alter
antigen
process
present
machineri
activ
matur
dendrit
cell
apc
also
drive
alter
cellular
traffick
pattern
collect
bring
apc
lymphocyt
togeth
order
effect
initi
activ
clonal
expans
pathogenspecif
lymphocyt
popul
still
factor
provid
costimul
serv
growth
differenti
factor
antigenspecif
b
lymphocyt
adjuv
compound
improv
vaccin
efficaci
recent
aluminum
salt
adjuv
use
vaccin
formul
us
knowledg
innat
immun
system
recogn
respond
pathogen
increas
abil
control
direct
innat
adapt
immun
respons
use
novel
adjuv
adjuv
boost
immun
respons
varieti
mechan
immunomodul
cytokin
upregul
depot
gener
target
antigen
appropri
apc
enhanc
antigen
present
combin
effect
current
oilinwat
emuls
alum
absorb
agonist
virosom
use
commerci
vaccin
product
furthermor
wide
varieti
vaccin
adjuv
test
human
promis
result
includ
tlr
agonist
cpg
deriv
imidazoquinolin
polyi
c
flagellin
oilinwat
waterinoil
emuls
miner
oil
squalen
copolym
liposom
nanoparticl
isocm
calcium
salt
proteasomesvirosom
muramyl
dipeptid
deriv
saponin
lipid
bacteri
toxin
cytokin
continu
influenza
vaccin
analog
multipl
adjuv
success
test
clinic
trial
combin
influenza
vaccin
special
interest
develop
improv
ie
greater
immun
respons
antigen
spare
crossreact
immun
vaccin
exampl
illustr
one
appli
current
insight
innat
immunolog
adjuv
mechan
action
order
optim
vaccin
develop
judici
select
adjuv
particular
one
take
success
vaccin
formul
combin
sever
differ
adjuv
uniqu
tailor
individu
group
within
popul
one
might
target
strong
adjuv
formul
elderli
order
overcom
immunosenesc
altern
one
might
util
promot
adjuv
pregnant
women
predispos
respons
vaccin
target
pathogen
hcv
hiv
requir
strong
cellular
immun
respons
likewis
immunocompromis
individu
requir
inactiv
subunit
vaccin
may
benefit
adjuv
version
safe
effect
replac
danger
signal
present
live
viru
vaccin
similarli
vaccin
target
respiratori
pathogen
may
benefit
adjuv
promot
mucos
immun
benefit
understand
innat
respons
go
beyond
adjuv
select
implic
vaccin
safeti
well
adjuv
use
increas
must
care
monitor
potenti
side
effect
adjuv
test
facilit
detail
knowledg
regard
mechan
action
pathway
stimul
compound
downstream
immunolog
consequ
stimul
specif
pathway
turn
knowledg
allow
us
establish
relev
biomark
quickli
care
assess
individu
respons
compound
necessari
treat
potenti
complic
quickli
exampl
one
studi
examin
earli
gene
express
event
vaccin
note
upregul
ifninduc
gene
correl
system
advers
event
potenti
creat
biomark
predict
reactogen
strong
earli
ifn
respons
preced
damag
inflammatori
reaction
one
manag
side
effect
even
engin
vaccin
avoid
overactiv
inflammatori
respons
assess
potenti
innat
immun
marker
character
andor
predict
vaccineinduc
adapt
immun
andor
advers
event
current
experiment
approach
move
singl
biomark
experi
focus
assay
high
throughput
omic
base
assay
latter
includ
whole
genom
transcriptom
sequenc
next
gener
sequenc
genom
proteom
microarray
mass
spectrometrybas
proteom
multiplex
cytokinechemokin
assay
polychrom
flow
cytometri
highcont
assay
ligand
activationsuppress
innat
receptor
function
character
innat
immun
signal
cascad
high
throughput
assay
adjuv
activ
function
screen
etc
high
dimension
technolog
typic
produc
immens
amount
data
requir
sophist
comput
bioinformat
statist
analyt
approach
provid
system
level
inform
best
reflect
innateadapt
immun
interfac
summar
understand
innat
immun
adjuv
activ
increas
abl
appli
knowledg
judici
select
adjuv
order
control
vaccin
induc
immun
respons
result
vaccin
tailor
variou
popul
group
pregnant
women
infant
toddler
elderli
immunocompromis
individu
chronic
diseas
patient
confound
complic
preexist
diseas
poor
diet
nutrit
innat
immun
first
line
defens
care
monitor
initi
event
whether
gene
protein
level
provid
earli
biomark
allow
us
predict
immun
outcom
advers
event
diseas
sever
even
respons
therapi
microbiom
vaccin
respons
trillion
microbi
occup
easi
appreci
contribut
role
microbiom
play
health
diseas
human
microbiom
uniqu
person
blood
type
hla
class
high
level
sitespecif
divers
within
individu
symbiot
relationship
exist
host
commens
bacteria
influenc
genet
diet
environment
factor
disrupt
relationship
dysbiosi
lead
state
diseas
cultureindepend
highthroughput
sequenc
nongut
microbi
environ
reveal
distinct
microbiom
profil
associ
diseas
cystic
fibrosi
chronic
rhinosinus
tuberculosi
periodont
chronic
obstruct
pulmonari
diseas
coevolut
vertebr
speci
microbi
resid
thought
occur
benefici
metabol
process
dietari
nutrient
respons
immun
system
develop
accommod
complex
relationship
commens
microb
prevent
invas
infect
potenti
pathogen
along
tissuemicrobi
barrier
composit
microbiom
shape
manipul
releas
specif
antimicrobi
compound
prevent
growth
certain
microb
allow
other
flourish
system
spread
invad
microb
inhibit
releas
secretori
iga
epitheli
barrier
phagocytosi
compartment
immun
cell
deliveri
mesenter
lymphoid
tissu
consid
connect
system
secondari
lymph
organ
parallel
immun
system
influenc
microbiom
robust
immun
respons
reli
heavili
resid
microbi
environ
influenc
significantli
evid
lymphoid
organ
develop
germfre
anim
gut
associ
lymphoid
tissu
mesenter
lymph
node
peyer
patch
lymphoid
follicl
absent
diminish
size
mice
lack
inher
microbiota
microbiota
play
crucial
role
develop
expans
b
cell
context
microbi
infect
evid
suggest
host
microbiom
essenti
induct
immun
mous
model
infect
ichinoh
et
al
demonstr
host
microbiom
crucial
develop
adapt
respons
infect
influenza
viru
commensalderiv
signal
thought
contribut
antivir
respons
dampen
diseas
sever
influenza
infect
exampl
demonstr
amplitud
innat
adapt
immun
respons
infect
depend
interact
microbi
resid
person
medicinebas
therapi
alreadi
tailor
microbiom
environ
treatment
inflammatori
diseas
exampl
fecal
transplant
healthi
donor
effect
promis
treatment
recurr
clostridium
difficil
infect
approach
also
use
treat
inflammatori
bowel
diseas
coliti
insulin
resist
even
multipl
sclerosi
strong
evid
host
microbiom
influenc
immunolog
respons
next
logic
step
investig
influenc
microbiom
vaccineinduc
immun
exampl
specif
microbi
commun
associ
robust
respons
vaccin
perhap
research
focu
potenti
adjuv
deriv
microbi
commun
studi
begun
character
lung
microbiom
influenza
infect
insight
relationship
commens
pathogen
microb
present
influenza
infect
may
help
synthesi
novel
vaccin
therapeut
influenza
influenza
viru
known
alter
facilit
growth
dynam
certain
bacteri
speci
streptococcu
pneumonia
staphylococcu
aureu
speci
major
etiolog
contributor
secondari
pneumonia
influenza
infect
futur
person
vaccin
may
target
influenza
bacteri
speci
known
increas
growth
potenti
infect
oral
vaccin
may
also
avenu
person
medicin
target
toward
microbiom
compon
rout
administr
subsequ
interact
mucos
microbiota
summari
begin
understand
complex
relationship
microbi
cohabit
immun
person
medicin
vaccinolog
focus
individu
genet
makeup
signific
amount
success
advanc
afford
nextgener
sequenc
platform
like
miseq
desktop
sequenc
may
abl
develop
uniqu
fingerprint
individu
microbiom
clinic
set
could
inform
administr
person
vaccin
base
microbi
composit
well
appreci
host
genet
factor
influenc
host
suscept
infecti
diseas
well
known
genet
factor
similarli
affect
immun
respons
vaccin
truli
person
vaccinolog
approach
take
import
factor
consider
two
decad
use
recombin
hepat
b
vaccin
hbv
demonstr
signific
interindividu
differ
vaccineinduc
immun
genet
factor
affect
hepat
b
surfac
antigen
hbsag
specif
immun
respons
sever
hla
marker
individu
allel
extend
haplotyp
genet
polymorph
cytokin
tnf
cytokin
receptor
complement
immun
respons
gene
associ
nonrespond
respond
phenotyp
hbv
vaccin
suggest
genet
driver
differ
immun
respons
hbv
laboratori
publish
intens
topic
vaccin
immunogenet
critic
role
new
vaccin
develop
well
multipl
studi
viral
vaccin
immunogen
studi
demonstr
immun
respons
gene
polymorph
explain
part
variat
vaccineinduc
adapt
immun
respons
work
progress
candid
gene
associ
studi
genomewid
associ
studi
gwa
nextgener
transcriptom
examin
gene
set
function
pathway
system
level
studi
use
approach
explain
approxim
interindividu
variat
immun
respons
measl
vaccin
possibl
studi
potenti
influenc
number
gene
vaccin
respons
fact
earlier
work
select
gene
base
publish
literatur
biolog
plausibl
highli
like
involv
control
vaccin
immun
data
studi
measl
rubella
mump
influenza
vaccinia
viral
vaccin
demonstr
viral
receptor
hla
cytokinechemokin
cytokinechemokin
receptor
tolllik
receptor
vitamin
receptor
trim
key
immun
respons
gene
polymorph
significantli
influenc
adapt
immun
respons
follow
vaccin
also
research
across
multipl
viral
vaccin
model
measl
rubella
demonstr
genet
influenc
vaccin
respons
multigen
exampl
search
singl
nucleotid
polymorph
frequent
call
snp
contribut
variat
rubella
vaccineinduc
antibodi
level
identifi
total
snp
gene
control
immun
function
jointli
associ
variat
rubella
antibodi
level
four
snp
three
candid
gene
implic
snp
examin
individu
among
gene
cytokin
cytokin
receptor
lymphotoxin
alpha
lta
leukocyt
specif
antivir
effector
adar
ifntyp
iinduc
vitamin
receptor
famili
rarb
innat
antivir
factor
other
thu
populationbas
vaccin
studi
identifi
signific
polymorph
interest
addit
genet
variat
innat
antivir
gene
previous
link
host
suscept
viral
infect
west
nile
viru
hepat
c
viru
hepat
b
viru
sever
acut
respiratori
syndromesar
coronaviru
respons
interferon
therapi
snp
could
potenti
alter
express
andor
function
correspond
protein
subsequ
function
pathway
associ
variat
adapt
immun
respons
viral
vaccin
examin
impact
genet
polymorph
immun
respons
heterogen
sever
group
also
conduct
gwa
studi
examin
unbias
manner
influenc
genet
polymorph
innat
adapt
immun
respons
vaccin
studi
other
found
polymorph
known
novel
gene
previous
identifi
immun
function
associ
signific
interindividu
variat
immun
respons
valid
studi
well
studi
reveal
molecular
mechan
identifi
causal
gene
snp
necessari
next
step
influenza
serv
excel
exampl
contribut
immunogenet
understand
diseas
improv
vaccin
influenza
vaccin
offer
incomplet
protect
infect
complic
due
influenza
diseas
failur
rate
recent
observ
multipl
cluster
highli
pathogen
avian
influenza
infect
occur
among
genet
relat
individu
among
other
equal
close
contact
ill
index
case
home
report
indic
host
genet
influenc
suscept
sever
influenza
season
pandem
death
strongli
suggest
genet
associ
affect
immun
respons
viral
infect
limit
data
genet
studi
regard
influenc
gene
polymorph
includ
hla
influenza
vaccin
immun
respons
earli
report
suggest
class
hla
allel
might
influenc
immun
respons
influenza
antigen
find
yet
replic
confirm
report
identifi
sever
hla
class
ii
loci
associ
failur
mount
neutral
antibodi
respons
hla
class
ii
loci
associ
seroprotect
hai
titer
respons
given
role
hla
molecul
antigen
present
cell
examin
impact
hla
polymorph
immun
respons
influenza
vaccin
necessari
addit
hla
gene
rpain
also
shown
affect
host
immun
respons
influenza
viru
andor
replic
influenza
viru
studi
like
could
aid
develop
next
gener
influenza
vaccin
help
us
understand
genet
driver
immun
respons
genet
restrict
immun
vaccin
increasingli
appar
complex
biolog
process
immun
respons
far
sum
individu
part
recent
shift
emphasi
toward
studi
design
comprehens
character
immun
function
order
visual
understand
individu
compon
immun
respons
also
multifacet
interact
compon
examin
tempor
chang
occur
develop
immun
respons
system
biolog
defin
interdisciplinari
approach
combin
multipl
import
element
high
dimension
dataset
span
variou
biolog
space
genom
epigenom
transcriptom
proteom
metabolom
lipidom
microbiom
immunolog
clinic
outcom
multipl
timepoint
assess
tempor
chang
order
understand
big
pictur
integr
data
comput
model
analys
develop
rule
govern
system
order
predict
outcom
access
larg
quantiti
data
experiment
system
studi
key
system
biolog
high
throughput
omic
level
technolog
mass
spectrometri
next
gener
sequenc
antibodi
pathogen
proteom
microarray
allow
investig
comprehens
assess
biolog
system
eg
genom
transcriptom
proteom
fact
quickli
move
past
genom
era
studi
focus
proteom
metabolom
epigenom
ome
becom
increasingli
import
greatli
enrich
knowledg
biolog
high
dimension
result
combin
multiparamet
assess
immun
function
captur
humor
cellular
outcom
provid
rich
dataset
system
level
understand
obtain
excel
exampl
high
dimension
immun
phenotyp
polychromat
flow
cytometri
mass
spectrometri
allow
research
simultan
probe
immun
function
multipl
cellular
subset
softwar
system
alogrithm
develop
allow
research
handl
immens
amount
data
new
technolog
produc
bioinformat
comput
tool
allow
user
integr
interrog
dataset
order
observ
correl
understand
interact
network
identifi
molecular
andor
transcriptom
signatur
one
issu
monitor
human
immun
function
blood
readili
access
biolog
specimen
immun
respons
develop
lymph
node
site
infect
vaccin
fagerberg
et
al
integr
protein
express
data
multipl
tissu
cell
type
transcriptom
analysi
order
creat
updat
human
protein
atla
facilit
indepth
studi
specif
tissu
gene
andor
protein
larg
scale
system
biolog
studi
group
use
varieti
network
analysi
techniqu
detect
gene
express
signal
follow
vaccin
administr
promis
element
system
approach
abil
detect
novel
mechan
immun
function
refin
correl
protect
identifi
biomark
immun
respons
system
biolog
approach
appli
number
vaccin
promis
initi
result
first
system
biolog
studi
appli
vaccin
field
focus
yellow
fever
vaccin
studi
show
immun
respons
preced
express
level
chang
set
gene
interestingli
gene
coordin
regul
transcript
factor
control
type
ifn
respons
inflammasom
complement
furthermor
studi
initi
examin
gene
express
chang
integr
transcript
factor
bind
motif
inform
pathway
analysi
order
identifi
genom
signatur
cell
neutral
antibodi
respons
vaccin
investig
use
similar
approach
understand
immun
respons
season
influenza
vaccin
experiment
valid
find
use
ko
mice
influenza
vaccin
target
sever
system
biolog
studi
bucasa
et
al
identifi
express
signatur
correl
antibodi
respons
demonstr
high
respond
increas
express
gene
involv
ifn
signal
antigen
process
present
investig
team
also
conduct
analysi
integr
immunolog
transcriptom
data
wholegenom
genotyp
eqtl
analysi
combin
data
uncov
gene
genet
polymorph
influenc
humor
immun
follow
influenza
vaccin
furman
et
al
identifi
nine
paramet
ie
gene
express
serum
cytokin
cell
subset
phenotyp
collect
predict
antibodi
respons
influenza
vaccin
interestingli
three
studi
identifi
differ
gene
signatur
correl
hai
respons
differ
may
relat
variat
test
time
biospecimen
collect
andor
analyt
approach
indic
falseposit
signal
importantli
data
also
indic
respons
paramet
uniqu
individu
impli
may
multipl
signatur
vaccin
respons
element
signatur
may
common
among
vaccin
recipi
element
may
vari
contrast
sever
studi
identifi
similar
element
b
cell
transcript
signatur
correl
presenc
vaccinespecif
plasma
cell
highlight
import
caveat
studi
reconcil
differ
result
especi
given
complex
variat
immunophenotyp
high
dimension
data
acquisit
statist
analys
use
differ
group
anoth
import
point
consid
genet
signatur
select
base
statist
strength
biolog
per
se
therefor
import
reconnect
gene
relev
biolog
context
limit
address
consid
known
biolog
function
pathway
coregul
gene
set
gene
modul
obermos
et
al
examin
innat
adapt
respons
influenza
pneumococc
vaccin
within
context
function
group
gene
modul
expect
vaccin
elicit
express
profil
common
uniqu
element
vaccin
trigger
increas
gene
express
modul
associ
inflamm
apoptosi
cell
activ
protein
synthesi
influenza
vaccin
also
induc
strong
earli
ifn
respons
less
day
vaccin
investig
isol
varieti
lymphocyt
popul
track
signatur
monocyt
neutrophil
hand
pneumococc
vaccin
elicit
strong
plasmablast
signatur
day
data
made
publicli
avail
along
analyt
tool
order
allow
broader
access
primari
data
facilit
knowledg
discoveri
research
one
exampl
nih
fund
human
immunolog
project
consortium
hipc
http
wwwimmuneprofilingorg
ultim
goal
hipc
creat
publicli
avail
resourc
immun
profil
data
methodolog
tool
vaccin
made
remark
contribut
human
health
remain
one
costeffect
medic
intervent
yet
devis
howev
major
diseas
global
impact
vaccin
exist
ideal
target
next
gener
vaccin
product
histor
vaccin
made
empir
method
appli
entir
popul
one
size
fit
approach
approach
tremend
success
number
disadvantag
candid
vaccin
larg
develop
anim
model
must
enter
larg
expens
clinic
trial
demonstr
safeti
efficaci
vaccin
develop
also
reli
inconsist
incomplet
understand
correl
protect
current
issu
affect
vaccin
develop
particularli
complex
hypervari
organ
requir
shift
away
empir
approach
toward
direct
vaccin
develop
approach
capit
cut
edg
technolog
current
understand
innat
adapt
immun
function
increas
awar
vaccin
safeti
abil
predict
reduc
advers
event
effect
hostpathogen
interact
influenc
microbiom
import
realiz
human
divers
eg
genet
epigenet
chronolog
environment
result
wide
spectrum
interindividu
vaccin
respons
current
vaccin
vaccin
develop
approach
substanti
improv
human
health
approach
success
develop
protect
vaccin
pathogen
hepat
c
hiv
rhinovirus
etc
also
case
complex
organ
tuberculosi
malaria
parasit
fungal
organ
addit
current
empir
approach
vaccin
develop
slow
costli
ineffici
next
step
vaccin
develop
recogn
limit
challeng
realiz
need
person
vaccin
approach
tailor
need
recipi
point
view
recipi
current
immun
polici
conceiv
administ
populationlevel
paradigm
exampl
individu
genotyp
risk
chronic
infect
due
hepat
b
hpv
administ
costli
seri
three
vaccin
individu
immun
genotyp
allow
protect
immun
respons
singl
dose
vaccin
incur
expens
side
effect
time
paramet
administ
addit
two
dose
previous
comprehens
address
issu
review
paper
idea
person
vaccin
often
difficult
concept
scientist
understand
though
approach
alreadi
util
therapeut
cancer
vaccin
approach
increasingli
use
clinic
area
import
understand
point
time
difficult
conceiv
vaccin
develop
aim
singl
individu
rather
person
approach
base
common
understand
common
genotyp
gender
even
racial
group
exampl
vaccin
studi
date
healthi
nonimmunosenesc
femal
produc
higher
level
antibodi
viral
vaccin
male
receiv
dose
number
dose
given
vaccin
male
vaccin
creat
specif
hla
genotyp
base
hla
supertyp
process
alreadi
explor
laboratori
may
alter
even
avoid
immun
individu
base
immun
genotypephenotyp
signatur
might
predict
signific
advers
effect
given
vaccin
field
excit
earli
answer
concern
object
person
vaccinolog
approach
addit
person
vaccin
approach
may
lead
identif
effect
correl
protect
well
predict
biomark
concomit
improv
vaccin
safeti
efficaci
well
reduct
time
cost
requir
bring
new
vaccin
market
although
difficult
challeng
current
face
vaccinologist
also
know
innat
respons
adapt
immun
host
biolog
ever
similarli
possess
advanc
techniqu
comput
model
strategi
character
understand
human
immunolog
system
level
excel
posit
face
overcom
challeng
vaccinom
incorpor
use
omicslevel
technolog
genom
proteom
metabolom
appropri
measur
innat
adapt
immun
function
inform
regard
host
geneticsgenom
hostpathogen
interact
host
microbiom
data
integr
analyz
multipl
level
unsupervis
datadriven
analys
individu
paramet
analys
pathwaynetworkmodulegeneset
analys
incorpor
known
biolog
function
analys
follow
comput
predict
model
strategi
predict
analysi
microarray
knearest
neighbor
classif
nearest
centroid
support
vector
machin
discrimin
analysi
via
mix
integ
program
gener
linear
model
allow
investig
predict
immunogen
andor
vaccin
efficaci
result
studi
inform
vaccin
develop
clinic
trial
result
clinic
trial
lead
new
product
form
foundat
next
cycl
scientif
discoveri
